No Data
Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Corbus Pharmaceuticals Holdings Inc. Stock Rises Tuesday, Still Underperforms Market
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), Corbus Pharmaceuticals (CRBP) and Fortrea Holdings Inc. (FTRE)
Mizuho Securities Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating
Promising Potential of Corbus Pharmaceuticals: Buy Rating Reinforced by Key Assets and Strategic Focus
Express News | Corbus Pharmaceuticals Announces Dosing of First Patient in Its First-in-Human Study of Crb-601 to Treat Patients With Advanced Solid Tumors
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}